IRIS
PRINCIPI, MARIABEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.680
AS - Asia 3.837
EU - Europa 3.071
SA - Sud America 1.070
AF - Africa 142
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.517
SG - Singapore 1.514
IT - Italia 1.000
CN - Cina 851
BR - Brasile 826
HK - Hong Kong 488
SE - Svezia 441
RU - Federazione Russa 414
VN - Vietnam 314
DE - Germania 312
FR - Francia 198
GB - Regno Unito 196
FI - Finlandia 164
BD - Bangladesh 122
IN - India 113
UA - Ucraina 81
AR - Argentina 79
CA - Canada 70
ID - Indonesia 65
IQ - Iraq 62
BE - Belgio 55
MX - Messico 52
TR - Turchia 46
ZA - Sudafrica 46
PL - Polonia 41
CO - Colombia 40
PK - Pakistan 38
NL - Olanda 33
EC - Ecuador 32
VE - Venezuela 31
ES - Italia 30
JP - Giappone 30
UZ - Uzbekistan 26
SA - Arabia Saudita 25
CL - Cile 21
RO - Romania 21
PH - Filippine 20
MA - Marocco 17
IE - Irlanda 16
CI - Costa d'Avorio 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
MY - Malesia 14
PY - Paraguay 14
DZ - Algeria 13
EG - Egitto 13
TN - Tunisia 13
AU - Australia 12
PE - Perù 12
AT - Austria 11
AZ - Azerbaigian 11
KE - Kenya 11
GT - Guatemala 10
IL - Israele 9
KR - Corea 8
KZ - Kazakistan 8
LB - Libano 8
UY - Uruguay 8
NP - Nepal 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
JO - Giordania 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
EU - Europa 5
HN - Honduras 5
JM - Giamaica 5
LT - Lituania 5
CR - Costa Rica 4
GR - Grecia 4
KG - Kirghizistan 4
MK - Macedonia 4
PA - Panama 4
PS - Palestinian Territory 4
QA - Qatar 4
CH - Svizzera 3
ET - Etiopia 3
HU - Ungheria 3
LV - Lettonia 3
OM - Oman 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
EE - Estonia 2
FJ - Figi 2
GE - Georgia 2
IR - Iran 2
KW - Kuwait 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
Totale 18.803
Salva come PNG Salva come JPEG
Città #
Fairfield 1.284
Ashburn 1.049
Woodbridge 918
Singapore 807
Chandler 680
Houston 603
Seattle 510
Hong Kong 485
Cambridge 464
San Jose 459
Wilmington 422
Ann Arbor 420
Nyköping 361
Milan 339
Beijing 291
Dallas 238
Jacksonville 225
New York 197
Lawrence 132
Roxbury 130
Los Angeles 127
Nanjing 125
Rome 125
Lauterbourg 116
Council Bluffs 101
Ho Chi Minh City 101
Des Moines 79
Bari 78
Helsinki 76
Santa Clara 74
São Paulo 72
Princeton 71
Boardman 70
Inglewood 69
Columbus 59
Brussels 54
Brooklyn 53
Hanoi 53
Dearborn 52
San Diego 47
Buffalo 39
Chicago 39
Jakarta 38
London 38
Munich 37
Warsaw 36
Atlanta 35
Turin 34
Frankfurt am Main 32
The Dalles 29
Falkenstein 27
Figino 27
Shenyang 27
Dong Ket 26
Jiaxing 26
Montreal 26
Rio de Janeiro 26
Tianjin 25
Hebei 24
Nanchang 24
Tokyo 24
Paris 23
Johannesburg 22
Orem 22
Tashkent 22
Changsha 20
Mexico City 20
Baghdad 19
Belo Horizonte 19
Denver 18
Moscow 18
Boston 17
Dhaka 17
Dublin 17
Brasília 16
Chennai 16
Haiphong 16
Lahore 16
Medellín 16
Nuremberg 16
Stockholm 16
Abidjan 15
Bologna 15
Curitiba 15
Phoenix 15
Toronto 15
Pune 14
Ankara 13
Porto Alegre 13
Redwood City 13
Amsterdam 12
Da Nang 12
Guangzhou 12
Poplar 12
San Francisco 12
Buenos Aires 11
Falls Church 11
Naples 11
Santiago 11
Shanghai 11
Totale 12.864
Salva come PNG Salva come JPEG
Nome #
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 304
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 263
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 231
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 210
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 208
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 206
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 204
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 196
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 196
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 191
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 190
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 188
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 186
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 175
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 174
A mysterious case of gastroparesis: could the secret be found in a drink? 172
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 166
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 165
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 160
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 160
Estrogens, phytoestrogens and colorectal neoproliferative lesions 158
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 158
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 155
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 154
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 153
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 146
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 145
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 143
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 143
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 142
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 141
Celiac disease and common variable immunodeficiency: a familial inheritance? 141
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study 140
Alimentary disorders in young females with irritable bowel syndrome or ulcerative procto-sigmoiditis: A preliminary report. 137
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 137
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 136
The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy 134
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 134
The association between cardiac and gastrointestinal disorders: causal or casual link? 133
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 133
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 131
Oral Tacrolimus (FK-506) in Crohn' s disease complicated by fistulae of perineum 130
The cost of inflammatory bowel disease management matches with clinical course: A single outpatient centre analysis 130
Lactobacillus reuteri strain combination in helicobacter pylori infection: A randomized, double-blind, placebo-controlled study 129
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 127
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 127
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 126
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 122
La qualità della vita dei pazienti affetti da infiammazione intestinale 121
Pattern of apoptosis in Crohn’s disease: a singular aspect? 119
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 118
Seronegative celiac disease: where is the specific setting? 111
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 111
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 111
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 110
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 110
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 107
La gastrite cronica da Helicobacter Heilmannii: una nuova entità istopatologica. L’ infezione da Helicobacter pilori: aggiornamento continuo G Bianchi Porro, G Maconi, F Parente 106
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 106
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study 106
Effect of Helicobacter Pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression 105
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. 102
New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study 102
Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic 101
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 101
null 101
null 100
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data] 100
null 99
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 97
Appliance of immunohistochemical techniques in Helicobacter pylori infection. Immunohistochemistry and Helicobacter pylori 96
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 96
null 94
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 94
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 94
Liver involvement in inflammatory bowel disease: What should the clinician know? 93
Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn disease: a case report 92
Probiotics and Helicobacter pylori 91
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 91
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 91
null 90
Differential immunohistochemical expression of Syndecan-1 and Tumor necrosis factor alpha in colonic mucosa of patients with Crohn’s disease 90
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? 89
null 89
Mucosal expression of Basic Fibroblastic Growth Factor, Syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies 89
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis 89
Long-term tacrolimus: a promising therapeutic approach for Crohn’s disease 88
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 87
Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: A preliminary report. 87
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 86
null 86
null 86
Prevalence and clinical significance of incidental extra-intestinal findings in MR enterography: experience of a single University Centre 86
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 86
null 85
Letter: Portal vein obstruction - Which subset of patients could benefit the most? 85
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 85
Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study 84
Immunosuppressant supplementation to infliximab in Crohn's disease with extraintestinal involvement: A benefit in the long term? 84
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 83
Totale 12.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.941
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.029 101 44 37 37 54 101 27 55 61 90 166 256
2022/20231.688 241 235 124 140 154 239 23 184 261 12 47 28
2023/2024566 35 107 23 55 52 163 14 22 6 27 13 49
2024/20252.524 40 36 161 76 57 218 337 234 107 144 398 716
2025/20266.597 882 352 434 632 729 320 620 196 823 628 269 712
2026/2027420 420 0 0 0 0 0 0 0 0 0 0 0
Totale 19.515